Table 2.
Comparison of demographic and clinical baseline characteristics of inpatient survivors with and without persistent symptoms of COVID-19 one year after hospital discharge
| Persistent symptoms related to COVID-19 N = 56 |
No persistent symptoms related to COVID-19 N = 106 |
p-value | |
|---|---|---|---|
| Gender | |||
| Female, N (%) | 25 (44.6) | 49 (46.2) | 0.89 |
| Age, Mean (SD) | 62.2 (16.9) | 66.6 (17.2) | 0.12 |
| Age group | |||
| < 20 years (%) | 1 (1.8) | 0 | 0.15 |
| 20–39 years (%) | 2 (3.6) | 8 (5.1) | |
| 40–59 years (%) | 18 (32.1) | 26 (46.4) | |
| 60–79 years (%) | 25 (44.6) | 42 (26.9) | |
| > 80 years (%) | 10 (17.8) | 29 (18.6) | |
| Nursing home resident, N (%) | 5 (8.9) | 21 (19.8) | 0.0004 |
| German place of residence, N (%) | 101(95.3) | 54 (96.4) | 0.94 |
| Working, N (%) | 26 (46.4) | 40 (37.7) | 0.31 |
| Number of active comorbidities, N (%) | 1.6 (1.3) | 2.0 (1.6) | 0.06 |
| Number of COVID-19 symptoms at admission, Mean (SD) | 3.5 (2.2) | 2.2 (2.2) | 0.17 |
| CRP at the time of admission to COVID-19 ward (mg %; normal < 5 mg%) | 63.0 (63.2) | 43.3 (55.5) | 0.05 |
| LDH at the time of admission to COVID-19 ward (U/l); normal < 220 U/l | 324 (129) | 281 (112) | 0.08 |
| COVID-19 severity | |||
| Asymptomatic | 7 (12.5) | 40 (37.7) | 0.02 |
| Mild | 16 (28.6) | 22 (20.8) | |
| Moderate | 16 (28.6) | 24 (22.6) | |
| Severe | 14 (25.0) | 19 (17.9) | |
| Critical | 2 (3.6+) | 1 (0.9) | |
| Critical (Multiorgan failure) | 1 (1.8) | 0 | |
| Management | |||
| Oxygen in ward | 30 (53.8) | 36 (34.0) | 0.02 |
| Noninvasive ventilation in ICU | 2 (3.6) | 5 (4.7) | 0.44 |
| Invasive ventilation in ICU | 3 (5.4) | 1 (0.9) | 0.09 |
| ECMO | 1 (1.8) | 0 | – |
| Length of hospital stay in days, Mean (SD) | 10.4 (10.8) | 9.2 (8.2) | 0.02 |